Aventis/Genta Genasense Lead Indication To Be Decided This Summer

Aventis and Genta expect to determine which cancer indication to pursue for Genasense by the summer

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet